NIH-funded research R01 grant

Novel alveolar factors driving low oxygen in liver-related lung disease

Official title: Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome

Funded at University of Arizona · NIH-11401062 · Data updated 2026-11-12

A patient-focused study will explore how high bile acids in cirrhosis may harm tiny air sacs in the lungs, causing breathing problems in hepatopulmonary syndrome.

More Hypoxemia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 1, 2023
Project endJune 30, 2027
Funding year2026
Award (this year)$736,127
NIH project number5R01HL169509-04
Project IDNIH-11401062 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cirrhosis and hepatopulmonary syndrome or those undergoing related assessments who could contribute samples or participate in studies on lung function and bile acids.

Less likely to help

People without cirrhosis or hepatopulmonary syndrome or who do not have access to related clinical evaluations may not benefit from this research.

What this research studies

This project looks at how cirrhosis-related changes in the blood can affect the lungs’ air sacs (alveoli), potentially leading to worse oxygenation. Researchers will examine how bile acids interact with alveolar type 2 cells to alter surfactant and lung function. The team will link bile acid levels to HPS severity, study AT2 cell roles, and uncover how bile acids may cause AT2 cell loss, aiming to reveal new therapeutic targets. The work uses both experimental models and human data to bridge gaps between liver disease and lung outcomes.

Why it matters

Potential benefit: If successful, the findings could point to new treatments that improve breathing and survival for people with hepatopulmonary syndrome.

How similar studies have gone: Previous work has shown links between bile acids and lung cell function, but this project aims to clarify mechanisms specific to HPS, representing a novel but promising area.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Fallon, Michael B — University of Arizona
  • Study coordinator: Fallon, Michael B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.